Tracker / Changelog

Changelog

Every addition and correction to the Tracker is logged here, newest first.

  1. The Register is now called the Pharma AI Tracker. The address moved from /pharma-ai-register/ to /pharma-ai-tracker/, with permanent redirects from the old address.

  2. Nineteen companies were added: Otsuka Holdings, Alnylam Pharmaceuticals, Daiichi Sankyo, Celltrion, Astellas Pharma, Roivant Sciences, Hansoh Pharmaceutical, Insmed, Incyte, BioNTech, Genmab, Innovent Biologics, Viatris, United Therapeutics, Torrent Pharmaceuticals, Shionogi, Jazz Pharmaceuticals, Sobi and PharmaEssentia. A CSL and AWS collaboration entry was added for AI and cloud work in research and clinical development. The Tracker covers 49 companies and 349 sourced entries. Ninety-one new entries were added.

  3. Five companies were added: Galderma, Jiangsu Hengrui, Revolution Medicines, BeOne and Sandoz. The Tracker covers 30 companies and 258 sourced entries. Fifteen new entries were added. A new AI drug discovery category covers companies' in-house discovery work, which had been grouped with research partnerships.

  4. Pharma AI Tracker launched, covering the top 25 pharma companies by market cap with 243 sourced entries, each linked to a public source. The default view shows 165 entries; research partnerships (78) can be shown with a toggle. The leaderboard, which counts disclosed AI use cases since January 2023, launched alongside it.